RePORT ⟩ RePORTER

Project Details

IGF::OT::IGF: Developing a Virtual Environment to Enhance Patient Engagement in Peer Support in Opioid Use Disorder. September 22, 2017 - March 21, 2018. N43DA-17-5586. Base Award

Project Number271201700057C-0-0-1

Contact PI/Project LeaderMCFARLAND, IAN

Awardee OrganizationPEAR THERAPEUTICS, INC.

Description

Abstract Text

The primary objective of this project is to develop and test a virtual reality (VR) environment for facilitating peer mentoring and support for patients with opioid use disorder. Pear Therapeutics and collaborators (CleanSlate Research and Education Foundation (CREF)) will design, build and test the VR environment as outlined in Specific Aim 1. Exploratory research will be conducted in Specific Aim 2 to understand the feasibility of implementing VR environments for peer support.

Public Health Relevance Statement

Data not available.

NIH Spending Category

Drug Abuse (NIDA only)Networking and Information Technology R&DSubstance Abuse

Project Terms

Adverse effectsAwardCommunitiesComputer softwareDevelopmentEducationEnvironmentFeedbackFeesFoundationsHealth PersonnelHealth ProfessionalHealthcareMeasuresModelingPatientsPearPerceptionResearchSocial supportSupport GroupsTestingTherapeuticTranslatingTreatment outcomebasedesignexperiencemeetingsmentoring communityopioid use disorderpeerpeer coachingpeer supportprototypeusabilityvirtual reality

Details

Contact PI/ Project Leader

Name

MCFARLAND, IAN

Title

Contact

Other PIs

Not Applicable

Program Official

Name

Contact

Email not available

Organization

Name

PEAR THERAPEUTICS, INC.

City

Boston

Country

UNITED STATES (US)

Department Type

Unavailable

Organization Type

Domestic For-Profits

State Code

Congressional District

Other Information

Opportunity Number

Study Section

Fiscal Year

2017

Award Notice Date

Administering Institutes or Centers

National Institute on Drug Abuse

CFDA Code

DUNS Number

079705123

UEI

LBWUKD3WN139

Project Start Date

22-September-2017

Project End Date

21-March-2018

Budget Start Date

Budget End Date

Project Funding Information for 2017

Total Funding

$149,514

Direct Costs

Indirect Costs

Year	Funding IC	FY Total Cost by IC
2017	National Institute on Drug Abuse	$149,514

NIH Categorical SpendingClick here for more information on NIH Categorical Spending

Funding IC	FY Total Cost by IC	NIH Spending Category
NATIONAL INSTITUTE ON DRUG ABUSE	$149,514	Drug Abuse (NIDA only); Networking and Information Technology R&D (NITRD); Substance Misuse

Sub Projects

No Sub Projects information available for 271201700057C-0-0-1

Publications

Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.

No Publications available for 271201700057C-0-0-1

Patents

No Patents information available for 271201700057C-0-0-1

Outcomes

The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.

No Outcomes available for 271201700057C-0-0-1

Clinical Studies

No Clinical Studies information available for 271201700057C-0-0-1

News and More

Section Menu